ZMIZ1 and Cognitive impairment: These developmental and structural abnormalities manifest as behavioral disorders, including intellectual impairment, speech development delay, seizures, impaired motor function, social-behavioral deficits, and cognitive deficits which are observed phenotypes in human patients with Zmiz1 de novo mutations and correlate to ASD patients (3, 9, 10, 47–49, 82–87).